rs1800579
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000361.3(THBD):c.1502C>T(p.Pro501Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00268 in 1,608,780 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P501P) has been classified as Likely benign.
Frequency
Consequence
NM_000361.3 missense
Scores
Clinical Significance
Conservation
Publications
- atypical hemolytic-uremic syndrome with thrombomodulin anomalyInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- thrombomodulin-related bleeding disorderInheritance: AR, AD, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- atypical hemolytic-uremic syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000361.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 294AN: 152240Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00180 AC: 422AN: 234646 AF XY: 0.00184 show subpopulations
GnomAD4 exome AF: 0.00275 AC: 4010AN: 1456422Hom.: 9 Cov.: 30 AF XY: 0.00276 AC XY: 1996AN XY: 724188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00193 AC: 294AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.00184 AC XY: 137AN XY: 74496 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.